Z-1320-2015 Class III Terminated
FDA device recall Z-1320-2015 was initiated by Roche Molecular Systems, Inc. on Jan 13, 2015 and is designated Class III. Reason for recall: False positive results for Exon 20 insertion mutations are being detected with the cobas¿ EGFR Mutation Test, kit batch T08661. The recall status is terminated (terminated Dec 11, 2017). Affected quantity: 190 kits.
Recall details
- Product Type
- Devices
- Report Date
- Apr 1, 2015
- Initiation Date
- Jan 13, 2015
- Termination Date
- Dec 11, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 190 kits
Product description
cobas¿ EGFR Mutation Test epidermal growth factor receptor (EGFR) gene DNA assay
Reason for recall
False positive results for Exon 20 insertion mutations are being detected with the cobas¿ EGFR Mutation Test, kit batch T08661.
Distribution pattern
Foreign
Code information
T08661
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1320-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026